Lobbying Filing Details

Total Spending

$80,000

Activities

3

Lobbyists

9

Gov't Entities

6

Filing Information
Filing UUID:
2fdac02a-ba81-4bdb-a621-28f26baa836b
Type:
Q4 - 4th Quarter - Report
Period:
2013 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 16, 2014 at 3:40 PM
Income:
$80,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Karina Lynch, Principal
Registrant
WILLIAMS AND JENSEN, PLLC

Lobbying Law Firm

Washington, District of Columbia
Client
SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE

regenerative medicine company; develops and commercializes bioengineered tissue products

Connecticut, United States of America
Lobbying Activities (3)
Activity 1
Health Issues

General health care reform; CMS coding coverage issues. Issues related to attention deficit hyperactivity disorder (ADHD) medicines

Lobbyists (3)
  • GEORGE OLSEN
  • KARINA LYNCH
  • MR. DAVID A STARR
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

CMS bundling rules for the hospital outpatient prospective payment system. ACA implementation. Rebates for Medicare Part D.
House and Senate action on H.J. Res. 59 and possible drug industry issues. The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013

Lobbyists (6)
  • JENNY DIJAMES
  • GEORGE OLSEN
  • KARINA LYNCH
  • MS. MELINDA M MAXFIELD
  • MR. MATTHEW B HOEKSTRA
  • ERIN BOOK MULLEN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Taxation/Internal Revenue Code

Tax issues affecting the pharmaceutical industry. Casey SGR amendment.

Lobbyists (4)
  • BERTRAM CARP
  • GEORGE OLSEN
  • KARINA LYNCH
  • MR. CHRISTOPHER W HATCHER
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.